Differential expression of GPR160 in amyotrophic lateral sclerosis.

Abstract: Neurodegenerative diseases that affect the motor neurons, including amyotrophic lateral sclerosis (ALS), have little treatment options and are generally rapidly fatal (1, 2). We harnessed the power of unbiased, whole transcriptome differential gene expression analysis, utilizing primary patient cells and tissues to discover genes whose expression defines ALS using published data (3, 4). We found significant differential expression of GPR160, encoding G protein-coupled receptor 160, in the motor neurons of patients with ALS. GPR160 was also differentially expressed in the induced pluripotent stem cell (iPSC)-derived motor neurons of patients with ALS. GPR160 transcript was present at lower levels in ALS patient motor neurons as compared to control motor neurons. These analyses will begin to define the transcriptional landscape of ALS.